ABBV
AbbVie Inc.
Cash flow statement
| USDLine, in USD | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 20.1B | 19.0B | 18.8B | 22.8B | 24.9B | 22.8B | 17.6B | 13.3B | 13.4B | 10.0B | 7.0B | 7.5B | 3.5B | 6.3B | 6.3B | 6.2B |
| 1.22B | 1.21B | 0.97B | 0.78B | 0.70B | 0.79B | 0.80B | 0.55B | 0.64B | 0.53B | 0.48B | 0.53B | 0.61B | 0.49B | 0.33B | 0.36B | |
| Free cash flow | 18.9B | 17.8B | 17.8B | 22.1B | 24.2B | 22.0B | 16.8B | 12.8B | 12.8B | 9.4B | 6.6B | 7.0B | 2.9B | 5.8B | 6.0B | 5.9B |
| Depreciation and amortization | 7.71B | 8.14B | 8.39B | 8.70B | 8.47B | 8.52B | 6.47B | 2.02B | 1.77B | 1.50B | 1.19B | 0.84B | 0.79B | 0.90B | 1.15B | 1.27B |
| Stock-based compensation | 927M | 955M | 911M | 747M | 671M | 692M | 753M | 430M | 421M | 365M | 353M | 282M | 241M | 212M | 187M | 163M |
| Buybacks | 1.5B | 980M | 1.7B | 2.0B | 1.5B | 934M | 978M | 629M | 12.0B | 1.4B | 6.0B | 7.6B | 665M | 320M | — | — |
| Dividends paid | 12.1B | 11.7B | 11.0B | 10.5B | 10.0B | 9.3B | 7.7B | 6.4B | 5.6B | 4.1B | 3.7B | 3.3B | 2.7B | 2.6B | — | — |
| Dividends per share | 6.92 | 6.65 | 6.29 | 5.99 | 5.71 | 5.31 | 4.84 | 4.39 | 3.95 | 2.63 | 2.35 | 2.10 | 1.75 | 2.00 | — | — |
| Free cash flow margin | 28.6% | 29.1% | 31.7% | 40.6% | 41.8% | 39.1% | 36.7% | 38.4% | 39.0% | 33.4% | 25.6% | 30.6% | 14.7% | 30.7% | 32.7% | 33.8% |